Pediatric Infection and Vaccine

The Korean Society of Pediatric Infectious Diseases (대한소아감염학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical and Laboratory Findings of the 2012 Winter Seasonal Influenza A and B Outbreak at a Single Institution

계절 인플루엔자: 단일기관 연구

  • Choi, Jae Won (Department of Pediatrics, Yonsei University, Wonju College of Medicine) ;
  • Cho, Hyun Jun (Department of Pediatrics, Yonsei University, Wonju College of Medicine) ;
  • Kim, Hwang Min (Department of Pediatrics, Yonsei University, Wonju College of Medicine) ;
  • Hahn, Seok (Department of Radiology, Yonsei University, Wonju College of Medicine)
  • 최재원 (연세대학교 원주의과대학 소아과학교실) ;
  • 조현준 (연세대학교 원주의과대학 소아과학교실) ;
  • 김황민 (연세대학교 원주의과대학 소아과학교실) ;
  • 한석 (연세대학교 원주의과대학 영상의학과학교실)
  • Received : 2013.07.16
  • Accepted : 2013.10.24
  • Published : 2014.04.25
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The aim for this study was to investigate clinical manifestation of seasonal influenza A and B during the 2012 winter season in Wonju, South Korea. Their clinical and laboratorial characteristics and effect of oseltamivir were compared and analyzed. Methods: Children under the age of 18 years who visited the Wonju Severance Christian Hospital with fever or acute respiratory symptoms and who were diagnosed with influenza A or B by rapid antigen test from nasopharyngeal swab were selected for the study. The medical records of patients were retrospectively reviewed. Results: Influenza A was detected in 374 patients (83.7%), and influenza B in 72 (16.6%). The incidence of influenza A was highest in February (n=186), while that of influenza B was highest in March (n=36). The most common symptoms were fever (n=434, 97.1%) and cough (n=362, 81.0%). No significant differences were observed between influenza A and B in symptoms and laboratory data. Patients who had used oseltamivir within 2 days showed statistically lower admission rate, shorter admission duration, and lower incidence of pneumonia. Conclusion: This study found no statistical difference between influenza A and B, in symptoms, progression, and laboratory test, but those who were treated with oseltamivir given within 2 days of the onset of fever experienced more positive outcomes.

목적: 인플루엔자 바이러스는 전세계적으로 소아 급성호흡기 감염의 주된 원인 바이러스로, 5세 미만 환아에서 매년 높은 이환율과 사망률이 보고되고 있다. 본 연구에서는 2012년 원주지역에 발생한 A형 인플루엔자 및 B형 인플루엔자의 임상양상의 차이, oseltamivir 투약군과 비투약군의 차이를 비교, 분석하여 향후 치료 및 예후 판단에 도움을 얻고자 하였다. 방법: 2012년 1월부터 3월까지 원주 세브란스 기독병원에 내원한 18세 이하의 환아 중, 인플루엔자 신속 항원검사 양성으로 보고된 환아를 대상으로 후향적으로 조사하였다. 결과: 연구기간 동안 A형 인플루엔자 환아는 374명(83.7%), B형 인플루엔자 환아는 72명(16.6%)이 보고되었다. 시기적으로 A형 인플루엔자는 2월에 가장 많았으며(n=186), B형 인플루엔자는 3월에 가장 많은 수가 보고되었다(n=36). 발열이 가장 흔한 증상이였고(97.1%), 그 외 기침, 콧물, 가래 순으로 증상이 관찰되었으며 증상 및 검사실 결과에서 인플루엔자 A, B형 간에 통계학적으로 의미 있는 차이는 없었다. oseltamivir 치료 시, 특히 발열 후 2일 이내에 투여한 경우에 비치료군에 비하여 입원율 및 입원 기간, 폐렴의 발생 빈도가 통계적으로 낮게 나타났다. 결론: 본 연구에서는 인플루엔자 A와 B 군간의 혈액검사 및 증상, 경과 등에는 통계학적으로 유의한 차이가 관찰되지 않았으나, oseltamivir 처방을 받은 환아나, 발열 2일 내에 치료를 시행한 경우 더 양호한 경과를 보였다.

Keywords

References

  1. Korea Centers for Disease Control and Prevention. Korean influenza surveillance report, 2011-2012. Public Health Weekly Report 2012;5:873-81. Available at http://www.cdc.go.kr/CDC/info/CdcKrInfo0301.jsp?menuIds=HO ME001-MNU0004-MNU0036-MNU0037 [accessed on 12 Sep 2013].
  2. Wright P. Influenza viruses. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Nelson Textbook of Pediatrics. 19th ed. Philadelphia: WB Saunders, 2011:1121-5.
  3. Ginocchio CC, Zhang F, Manji R, Arora S, Bornfreund M, Falk L, et al. Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol 2009;45:191-5. https://doi.org/10.1016/j.jcv.2009.06.005
  4. Blyth CC, Iredell JR, Dwyer DE. Rapid-test sensitivity for novel swine-origin influenza A(H1N1) virus in humans. N Engl J Med 2009;361:2493. https://doi.org/10.1056/NEJMc0909049
  5. Kim WJ. Epidemiology, clinical manifestations, and management of pandemic novel Influenza A (H1N1). The Korean J Med 2009;77:157-64.
  6. Wie SH, So BH, Song JY, Cheong HJ, Seo YB, Choi SH, et al. A comparison of the clinical and epidemiological characteristics of adult patients with laboratory-confirmed influenza A or B during the 2011-2012 influenza season in Korea: a multi-center study. PLoS ONE 2013;8:e62685. https://doi.org/10.1371/journal.pone.0062685
  7. Kim SH, Park CH, Huh K, Shim GH, Kim HB, You SJ, et al. Comparison of clinical manifestation and laboratory findings between H1N1 and influenza B infection. Pediatr Allergy Respir Dis 2012;22:64-70. https://doi.org/10.7581/pard.2012.22.1.64
  8. Yang SI, Rho JH, Sun YH, Cho KH, Shim SY, Eun BW, et al. The comparison of clinical characteristics and courses of pediatric patients hospitalized with pandemic influenza A (H1N1) and seasonal influenza from 2009 to 2011. Pediatr Allergy Respir Dis (Korea) 2012;22:292-301. https://doi.org/10.7581/pard.2012.22.3.292
  9. Kawai N, Ikematsu H, Iwaki N, Kawashima T, Maeda T, Mitsuoka S, et al. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir. J Infect 2007;55:267-72. https://doi.org/10.1016/j.jinf.2007.05.176
  10. Sato M, Saito R, Sato I, Tanabe N, Shobugawa Y, Sasaki A, et al. Effectiveness of oseltamivir treatment among children with influenza A or B virus infections during four successive winters in Niigata City, Japan. Tohoku J Exp Med 2008;214:113-20. https://doi.org/10.1620/tjem.214.113
  11. Wang K, Shun-Shin M, Gill P, Perera R, Harnden A. Neuraminidase inhibitors for preventing and treating influenza in children (published trials only). Cochrane Database Syst Rev 2012;4:CD002744.
  12. Samson M, Pizzorno A, Abed Y, Boivin G. Influenza virus resistance to neuraminidase inhibitors. Antiviral Res 2013;98:174-85. https://doi.org/10.1016/j.antiviral.2013.03.014
  13. de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 2005; 353:2667-72. https://doi.org/10.1056/NEJMoa054512
  14. Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, et al. Infections with oseltamivir-resistant influenza A(H1N1) virus in the united states. JAMA 2009;301:1034-41. https://doi.org/10.1001/jama.2009.294
  15. Seo ES, Park GH, Kim SM, Kim SW, Jung WS, Cho KS, et al. Oseltamivir efficacy, side effects, and safety in children with influenza. Korean J Pediatr 2010;53:56-66. https://doi.org/10.3345/kjp.2010.53.1.56
  16. Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1997;87:1944-50. https://doi.org/10.2105/AJPH.87.12.1944
  17. Thompson WW, Moore MR, Weintraub E, Cheng PY, Jin X, Bridges CB, et al. Estimating influenza-associated deaths in the United States. Am J Public Health 2009;99 Suppl 2:S225-30. https://doi.org/10.2105/AJPH.2008.151944
  18. van den Wijngaard CC, van Asten L, Meijer A, van Pelt W, Nagelkerke NJ, Donker GA, et al. Detection of excess influenza severity: associating respiratory hospitalization and mortality data with reports of influenza-like illness by primary care physicians. Am J Public Health 2010; 100:2248-54. https://doi.org/10.2105/AJPH.2009.168245
  19. Irving SA, Patel DC, Kieke BA, Donahue JG, Vandermause MF, Shay DK, et al. Comparison of clinical features and outcomes of medically attended influenza A and influenza B In a defined population over four seasons: 2004-2005 through 2007-2008. Influenza Other Respir Viruses 2012;6:37-43. https://doi.org/10.1111/j.1750-2659.2011.00263.x
  20. Morris SK, Parkin P, Science M, Subbarao P, Yau Y, O' Riordan S, et al. A retrospective cross-sectional study of risk factors and clinical spectrum of children admitted to hospital with pandemic H1N1 influenza as compared to influenza A. BMJ Open 2012;2:e000310. https://doi.org/10.1136/bmjopen-2011-000310
  21. Neuzil KM, Wright PF, Mitchel EF Jr, Griffin MR. The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr 2000;137:856-64. https://doi.org/10.1067/mpd.2000.110445

Cited by

  1. 단일 병원에서 2013-2015년에 유행한 인플루엔자 A형과 B형의 임상 양상 및 치료반응의 차이 vol.24, pp.1, 2014, https://doi.org/10.14776/piv.2017.24.1.16
  2. 인플루엔자 바이러스에 대한 신속 항원 검출 검사 검출한계의 융합적 분석 vol.9, pp.3, 2018, https://doi.org/10.15207/jkcs.2018.9.3.165